CancerGuide Diagnostics
CancerGuide, Duke Ink PGx Pact
The company will collaborate with Duke on cancer biomarker discoveries, and intends to use and commercialize the markers through agreements with drug developers.
CancerGuide Diagnostics Raises $10.5M, Inks Deal with LabCorp
The NC-based startup is led by a former LabCorp executive and is seeking partnerships to bring molecular diagnostic products to market.